Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
INVO Fertility, Inc. (IVF)
Sarasota, FL, US
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
3.02M
est: 3.59M (-15.8%)
|
6.53M
est: 6.35M (+2.9%)
|
6.84M
est: 7.19M (-4.8%)
|
10.42M
10.42M – 10.42M
+45.0% YoY
|
16.46M
16.46M – 16.46M
+58.0% YoY
|
26.01M
26.01M – 26.01M
+58.0% YoY
|
39.01M
39.01M – 39.01M
+50.0% YoY
|
52.67M
52.67M – 52.67M
+35.0% YoY
|
| EBITDA |
-6.88M
est: -3.59M (-91.7%)
|
-7.14M
est: -5.73M (-24.7%)
|
-3.51M
est: -6.48M (+45.9%)
|
-9.40M
-9.40M – -9.40M
-45.0% YoY
|
-14.86M
-14.86M – -14.86M
-58.0% YoY
|
-23.47M
-23.47M – -23.47M
-58.0% YoY
|
-35.21M
-35.21M – -35.21M
-50.0% YoY
|
-47.53M
-47.53M – -47.53M
-35.0% YoY
|
| EBIT |
-7.08M
est: -3.59M (-97.3%)
|
-8.06M
est: -5.85M (-37.7%)
|
-4.18M
est: -6.63M (+36.9%)
|
-9.61M
-9.61M – -9.61M
-45.0% YoY
|
-15.18M
-15.18M – -15.18M
-58.0% YoY
|
-23.99M
-23.99M – -23.99M
-58.0% YoY
|
-35.98M
-35.98M – -35.98M
-50.0% YoY
|
-48.58M
-48.58M – -48.58M
-35.0% YoY
|
| Net Income |
-8.03M
est: -541.13M (+98.5%)
|
-9.10M
est: -217.78M (+95.8%)
|
-23.32M
est: -17.39M (-34.1%)
|
-339.5K
-339.5K – -339.5K
+98.0% YoY
|
-117.1K
-117.1K – -117.1K
+65.5% YoY
|
41.0K
41.0K – 41.0K
+135.0% YoY
|
146.4K
146.4K – 146.4K
+257.1% YoY
|
251.7K
251.7K – 251.7K
+72.0% YoY
|
| SGA |
7.49M
est: 17.24M (-56.6%)
|
9.08M
est: 24.49M (-62.9%)
|
7.69M
est: 27.73M (-72.3%)
|
40.20M
40.20M – 40.20M
+45.0% YoY
|
63.52M
63.52M – 63.52M
+58.0% YoY
|
100.36M
100.36M – 100.36M
+58.0% YoY
|
150.54M
150.54M – 150.54M
+50.0% YoY
|
203.23M
203.23M – 203.23M
+35.0% YoY
|
| EPS |
-489.96
est: -1,748.16 (+72.0%)
|
-219.56
est: -1,860.00 (+88.2%)
|
-214.64
est: -148.55 (-44.5%)
|
-2.90
-2.90 – -2.90
+98.0% YoY
|
-1.00
-1.00 – -1.00
+65.5% YoY
|
0.35
0.35 – 0.35
+135.0% YoY
|
1.25
1.25 – 1.25
+257.1% YoY
|
2.15
2.15 – 2.15
+72.0% YoY
|
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IVF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
